Stockreport

NantKwest launches mid-stage study of triplet therapy for rare skin cancer [Seeking Alpha]

NANTKWEST  (NK) 
Last nantkwest earnings: 3/25 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nantkwest.com
PDF NantKwest launches mid-stage study of triplet therapy for rare skin cancer [Read more]